Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02046668Phase 4Completed
Phase 4, randomised, double-blind trial in osteoarthritis (OA) comparing Spironolactone with Placebo (2 arms). Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index pain subscale at 12 weeks. Started Nov 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02046668.